MetLife Investment Management’s Douglas Elliman DOUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,246
Closed -$62.2K 2788
2025
Q4
$62.2K Sell
26,246
-18,353
-41% -$47.2K ﹤0.01% 2708
2025
Q3
$128K Sell
44,599
-3,321
-7% -$8.71K ﹤0.01% 2538
2025
Q2
$111K Buy
+47,920
New +$102K ﹤0.01% 2486
2024
Q2
Sell
-49,364
Closed -$78K 2892
2024
Q1
$78K Buy
49,364
+228
+0.5% +$467 ﹤0.01% 2644
2023
Q4
$145K Hold
49,136
﹤0.01% 2412
2023
Q3
$111K Hold
49,136
﹤0.01% 2527
2023
Q2
$109K Sell
49,136
-1
-0% -$3 ﹤0.01% 2620
2023
Q1
$146K Hold
49,137
﹤0.01% 2391
2022
Q4
$190K Hold
49,137
﹤0.01% 2277
2022
Q3
$192K Buy
49,137
+6,699
+16% +$33.1K ﹤0.01% 2325
2022
Q2
$194K Hold
42,438
﹤0.01% 2344
2022
Q1
$295K Buy
42,438
+18,597
+78% +$141K ﹤0.01% 2106
2021
Q4
$261K Buy
+23,841
New +$268K ﹤0.01% 1886

Other funds holding DOUG

MetLife Investment Management's DOUG Position: Q1 2026 in Review

MetLife Investment Management sold out of Douglas Elliman (DOUG) in Q1 2026, closing a stake of 26,246 shares — an estimated $62.2K sold.

MetLife Investment Management first reported a position in DOUG in Q4 2021 and held it in 13 quarters. The position peaked at $295K in Q1 2022. 131 funds tracked by Wall St. Rank hold DOUG as of Q1 2026.

  • MetLife Investment Management reported no remaining Douglas Elliman position as of Q1 2026 after selling out during the quarter.
  • MetLife Investment Management sold 26,246 Douglas Elliman shares in Q1 2026, an estimated $62.2K.
  • MetLife Investment Management first reported a position in Douglas Elliman in Q4 2021 and held it in 13 quarters.
  • MetLife Investment Management's Douglas Elliman position peaked at $295K in Q1 2022.
  • 131 funds tracked by Wall St. Rank held Douglas Elliman as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.